Preliminary examination of the validity of the NIH toolbox cognition battery in treatment-resistant psychosis

被引:4
作者
Cassetta, Briana D. [1 ,2 ]
Menon, Mahesh [3 ,4 ]
Carrion, Prescilla B. [3 ]
Pearce, Hadley [3 ]
DeGraaf, Ashley [3 ]
Leonova, Olga [3 ]
White, Randall F. [3 ,4 ]
Stowe, Robert M. [3 ,5 ]
Honer, William G. [3 ,4 ]
Woodward, Todd S. [3 ,6 ]
Torres, Ivan J. [3 ,6 ]
机构
[1] Univ Calgary, Dept Psychol, Calgary, AB, Canada
[2] Vancouver Coastal Hlth, Vancouver, BC, Canada
[3] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
[4] BC Psychosis Program, Vancouver, BC, Canada
[5] Univ British Columbia, Dept Neurol, Vancouver, BC, Canada
[6] British Columbia Mental Hlth & Subst Use Serv, Vancouver, BC, Canada
关键词
treatment-resistant; psychosis; schizophrenia; cognition; NIH Toolbox; assessment; NEGATIVE-SYNDROME-SCALE; BEHAVIORAL FUNCTION; WAIS-IV; SCHIZOPHRENIA; SYMPTOMS; VALIDATION; IMPAIRMENT; CLOZAPINE; DEFICITS; PSYCHOPATHOLOGY;
D O I
10.1080/13854046.2019.1694072
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Prior research has suggested that treatment-resistant psychosis (TRP) may be a categorically distinct subtype from treatment-responsive psychotic disorders. However, relatively few studies have investigated the cognitive profile of individuals with TRP. Moreover, no prior studies have investigated the effectiveness of using the NIH Toolbox Cognition Battery (NTCB) for assessing cognition among psychiatric inpatients despite its promising efficiency and practicality in such settings. The current study aimed to investigate the validity of the NTCB and the associated cognitive profile of inpatients with TRP. Methods: Participants (N = 38) were administered the NTCB and a neuropsychological test battery. The Positive and Negative Syndrome Scale and the Routine Assessment of Patient Progress measured psychosis symptomatology and daily functioning, respectively. Results: Results showed deficits relative to normative values in fluid cognitive abilities using the NTCB, as predicted. There was strong convergent validity and adequate divergent validity between the NTCB subtests and corresponding neuropsychological measures, though no NTCB subtest correlated with performance on the Wisconsin Card Sorting Task. NTCB performance correlated with positive and disorganized symptoms of psychosis as well as daily functioning. Conclusions: Taken together, the NTCB appears to be a relatively strong tool for cognitive screening among psychiatric inpatients and may be used to identify which patients might benefit from further neuropsychological evaluation.
引用
收藏
页码:981 / 1003
页数:23
相关论文
共 81 条
  • [11] Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]
  • [12] Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia
    Burton, Cynthia Z.
    Vella, Lea
    Harvey, Philip D.
    Patterson, Thomas L.
    Heaton, Robert K.
    Twamley, Elizabeth W.
    [J]. SCHIZOPHRENIA RESEARCH, 2013, 146 (1-3) : 244 - 248
  • [13] Validation of the NIH Toolbox in Individuals with Neurologic Disorders
    Carlozzi, N. E.
    Goodnight, S.
    Casaletto, K. B.
    Goldsmith, A.
    Heaton, R. K.
    Wong, A. W. K.
    Baum, C. M.
    Gershon, R.
    Heinemann, A. W.
    Tulsky, D. S.
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2017, 32 (05) : 555 - 573
  • [14] Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study
    Chen, Bihong T.
    Sethi, Sean K.
    Jin, Taihao
    Patel, Sunita K.
    Ye, Ningrong
    Sun, Can-Lan
    Rockne, Russell C.
    Haacke, E. Mark
    Root, James C.
    Saykin, Andrew J.
    Ahles, Tim A.
    Holodny, Andrei I.
    Prakash, Neal
    Mortimer, Joanne
    Waisman, James
    Yuan, Yuan
    Somlo, George
    Li, Daneng
    Yang, Richard
    Tan, Heidi
    Katheria, Vani
    Morrison, Rachel
    Hurria, Arti
    [J]. BREAST CANCER RESEARCH, 2018, 20
  • [15] What cognitive changes can be expected with normal ageing?
    Christensen, H
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2001, 35 (06) : 768 - 775
  • [16] A POWER PRIMER
    COHEN, J
    [J]. PSYCHOLOGICAL BULLETIN, 1992, 112 (01) : 155 - 159
  • [17] An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions
    Crean, Rebecca D.
    Crane, Natania A.
    Mason, Barbara J.
    [J]. JOURNAL OF ADDICTION MEDICINE, 2011, 5 (01) : 1 - 8
  • [18] Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses
    de Bartolomeis, Andrea
    Balletta, Raffaele
    Giordano, Sara
    Buonaguro, Elisabetta Filomena
    Latte, Gianmarco
    Iasevoli, Felice
    [J]. PSYCHIATRY RESEARCH, 2013, 210 (02) : 387 - 395
  • [19] Delis D.C., 2001, Delis Kaplan Executive Function System Examiner's Manual
  • [20] Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia
    Deng, Huiqiong
    Kahlon, Ramandeep S.
    Mohite, Satyajit
    Amin, Pooja A.
    Zunta-Soares, Giovana
    Colpo, Gabriela D.
    Stertz, Laura
    Fries, Gabriel R.
    Walss-Bass, Consuelo
    Soares, Jair C.
    Okusaga, Olaoluwa O.
    [J]. PSYCHIATRIC QUARTERLY, 2018, 89 (01) : 53 - 60